when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

910 stories

May 15, 26Opinion: Telehealth abortion with mifepristone continues, with backup plans still in placestat

May 15, 26OncLive Polls Reveal Picks for Top GI Cancer Abstracts, Areas of Interest at ASCO 2026onclive

May 15, 26STAT+: Top U.S. officials pressured Germany to pay more for prescription drugsstat

May 15, 26PSA screening for prostate cancer reduces disease-specific deaths, new review showsstat

May 14, 26Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC Preventiononclive

May 14, 26Makary’s departure and Cassidy’s tenuous Senate seatstat

May 14, 26IO in NMIBC, Radioligand Therapy in mHSPC Highlight Key Presentations to Watch at AUA 2026onclive

May 14, 26Rintatolimod Plus Pembrolizumab and Cisplatin Displays 50% ORR in Recurrent Ovarian Canceronclive

May 14, 26Create Medicines raises $122M to bolster in vivo CAR-T therapiesbiopharma dive

May 14, 26Dana-Farber Study Finds Stage IV Breast Cancer Increasing in Incidence and Proportion Over the Last Decadeonclive

May 14, 26REVELUTION-2 Trial Is Evaluating Cardiovascular Risk With Relugolix Plus Abiraterone Acetate in High-Risk Prostate Canceronclive

May 14, 26AstraZeneca follows Merck with Phase 3 win in bladder cancerendpoints

May 14, 26STAT+: BeOne wins FDA approval in lymphoma racestat

May 14, 26MET Alterations in NSCLC: Amplification, Mutations, and Therapeutic Strategiesonclive

May 14, 26Planned HERIZON-GEA-01 Analyses and the Doublet-vs-Triplet Questiononclive

May 14, 26HERIZON-GEA-01 Efficacy Results and Interpretation of Duration of Responseonclive

May 14, 26STAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage studystat

May 14, 26STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 millionstat

May 14, 26STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submissionstat

May 13, 26Evolving Oral SERD Research Seeks to Redefine Treatment Strategies in Hormone Receptor+ Breast Canceronclive

May 13, 26Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practiceonclive

May 13, 26Opinion: The hantavirus is a wake-up call. Will the Trump administration answer it?stat

May 13, 26FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive

May 13, 26FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphomaonclive

May 13, 26Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AMLonclive

May 13, 26Future Directions in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Personalized Treatment Decision-Making in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26STAT+: What the Trump administration wants in its next FDA leaderstat

May 13, 26Future Radiopharmaceutical Strategies in Metastatic Castration-Resistant Prostate Canceronclive

May 13, 26Safety and Toxicity Management in Metastatic Castration-Resistant Prostate Canceronclive

← prevpage 23 of 31next →